INTRODUCTION
============

Bicuspid aortic valve (BAV) is one of the most common congenital cardiac anomalies that affects 1--2% of the global population.[@B1][@B2] BAV is defined as the morphological features of an aortic valve (AV) with "two cusps", and is associated with a variety of clinical manifestations that include hemodynamic alteration, premature valvular failure, aortic pathologies such as aneurysm or dissection, and association with other complex congenital disorders.[@B3][@B4][@B5] Little is known about the genetic components of BAV, as they range from single nucleotide polymorphisms to complex mutations, such as Notch homolog 1, translocation-associated (NOTCH1).[@B6] Several clinical studies on overall survival, incidence of adverse cardiac events, and aortic complications have been published recently.[@B7][@B8][@B9] Nevertheless, the current volume of evidence is insufficient, considering the many unanswered questions and clinical needs. A leading BAV research group recently suggested that current knowledge gaps need to be more clearly defined.[@B10]

To-date, most large-sized clinical studies are from western countries;[@B7][@B8][@B9] therefore, the possibility that ethnicity can be a potential disease modifier in BAV[@B11] needs to be examined. Specifically, there is a need for large-scale clinical evidence for Asian subjects. The Korean Bicuspid Aortic Valve (KoBAV) registry was launched in 2014 with 2 study arms. The prospective arm was designed to construct a cohort of newly diagnosed BAV patients for observation of long-term clinical consequences, and the retrospective arm included patients with full-blown BAV disease, with particular focus on their clinical presentations and morphological features. In the present report, we describe a large-sized patient group with BAV in Korea in terms of clinical features, patterns of practice, and morphological phenotypes.

METHODS
=======

Study outline
-------------

At a preliminary meeting of nationwide KoBAV researchers in April 2014, we proposed the outline of the present study. The enrollment criteria were: 1) adult patients aged ≥19, 2) AV surgery during 2000--2014, and 3) BAV confirmed in an operative or pathology report. We shared a standard case record form in which all the clinical and echocardiographic parameters were predefined. The definition of terminology, criteria for defining groups and protocols for image reviewing were fully explained before data collection. Finally, 4 tertiary referral centers (anonymized as center A to D) collaborated to construct a clinical and echocardiographic database of 1,160 patients (739 from center A, 223 from center B, 81 from center C, and 117 from center D; [Figure 1](#F1){ref-type="fig"}). The study protocol was approved by the ethics committee of each center, and informed consent was waived due to the retrospective nature of the study.

![Study outline for subject enrollment and analysis.\
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Clinical parameters
-------------------

The baseline clinical and echocardiographic data immediately before surgery (median interval of 7 days; interquartile range, 3--22) were obtained. All patients were categorized by dominant valvular pathologies for corrective surgery, which included aortic stenosis (AS, group I), aortic regurgitation (AR, group II), and active infective endocarditis (group III). Endocarditis was considered to be a prior criterion, regardless of dominant valvular dysfunction type, in patients that presented with typical clinical features of infective endocarditis. In other patients without infective endocarditis, more dominant moderate to severe valvular dysfunction was selected as an underlying valvular lesion for AV surgery. In rare cases with moderate to severe AS and AR, priority was given to AS. Demonstration of a 'typical double channel aorta with both the true and false lumen' on echocardiography or computed tomography (CT), which was confirmed during surgery, was required to define aortic dissection. Echocardiographic or CT demonstration of abnormal tissue thickening or cyst-like structures around the infected AV, which was confirmed during surgery, was used to define abscess. Aortic diameter greater than 45 mm on any imaging study was used as the definition of an aneurysm.[@B9]

BAV phenotype classification
----------------------------

We reviewed articles that discussed BAV phenotypes,[@B12][@B13] and categorized BAVs using morphological criteria based on cusp fusion patterns. One dedicated cardiologist was responsible for classifying the BAV phenotypes at each center, using the common protocol ([Figure 2](#F2){ref-type="fig"}). The examiner reviewed all echocardiographic images, including a transesophageal study that assessed 561 patients (48%). The practical steps for phenotype classification were also shared: 1) Define right coronary cusp (RCC) or left coronary cusp (LCC) as a reference on short axis image, considering the relationship with the coronary ostium and adjacent structures, such as right and left atria, right ventricular outflow tract and main pulmonary artery; 2) estimate other cusps based on the spatial relationship to the reference cusp, and because of possible image deviation, this was not based on apparent directions; and 3) determine the cusp fusion pattern by examining the conjoined motion during opening. Finally, the BAV morphological phenotypes were classified into 4 types: type 1, fusion between RCC and LCC; type 2, fusion between RCC and non-coronary cusp (NCC); type 3, fusion between LCC and NCC. We defined type 4 as those that were difficult to discriminate between type 2 or 3, while type 1 was clearly rejected due to the separation between RCC and LCC.

![Morphological criteria for BAV phenotype classification.\
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Data analysis
-------------

We presented categorical variables as numbers with percentages and continuous variables as mean±standard deviation. For comparison among the three groups, we used a χ^2^ test and 1-way analysis of variance (ANOVA) with the Bonferroni correction for categorical and continuous variables. All reported p values were 2-tailed and a p value of \<0.05 was considered statistically significant. SPSS software, version 22 (SPSS Inc., Chicago, IL, USA) was used for statistical analyses.

RESULTS
=======

Baseline characteristics
------------------------

The baseline clinical and echocardiographic characteristics are presented in [Table 1](#T1){ref-type="table"}. The mean age was 59±13 years and 763 patients (66%) were male. Prevalence of hypertension, diabetes and atrial fibrillation were 37%, 13%, and 8%, respectively. About 65% of patients presented with dyspnea of New York Heart Association (NYHA) functional class ≥2. Evaluation of echocardiographic parameters demonstrated that the mean left ventricular (LV) mass index was increased to 171±63 g/m^2^ with LV ejection fraction being preserved at 57±12%. The most common valvular pathology for surgery (number of patients \[%\]) was AS (892 \[77%\]), followed by AR (199 \[17%\]) and infective endocarditis (69 \[6%\]). [Figure 3](#F3){ref-type="fig"} shows the relationship between age and the dominant valvular lesion for AV surgery in patients with BAV. AS showed a skewed peak in the aged population and infective endocarditis occurred more frequently in young patients. AR showed a relatively symmetric distribution with a smooth peak in middle-aged patients ([Figure 3A](#F3){ref-type="fig"}). AS was the predominant valvular lesion (87%) in patients aged ≥50, whereas AR (46%) was predominant in those aged \<50 years (p\<0.001, [Figure 3B](#F3){ref-type="fig"}).

###### Baseline clinical and echocardiographic characteristics

![](kcj-48-48-i001)

  Variables                          Total patients (n=1,160)   
  ---------------------------------- -------------------------- ----------
  Age (years)                        59±13                      
  Male gender                        763 (66)                   
  Body surface area (m^2^)           1.69±0.18                  
  Hypertension                       429 (37)                   
  Diabetes                           145 (13)                   
  Coronary artery disease            162 (14)                   
  Smoking                            500 (43)                   
  Atrial fibrillation                92 (8)                     
  NYHA class                                                    
                                     0                          234 (20)
                                     1                          178 (15)
                                     2                          568 (49)
                                     3                          161 (14)
                                     4                          19 (2)
  LV mass index (g/m^2^)             171±63                     
  LV ejection fraction (%)           57±12                      
  Transesophageal echocardiography   561 (48)                   
  Dominant lesion for surgery                                   
                                     AS                         892 (77)
                                     AR                         199 (17)
                                     Infective endocarditis     69 (6)

Values are presented as mean±standard deviation or number of patients (%).

AR = aortic regurgitation; AS = aortic stenosis; LV = left ventricle; NYHA = New York Heart Association.

![Dominant valvular lesion for AV surgery according to the age groups by decades (A) and cut-off value of 50 years (B).\
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Clinical features based on main valvular pathology
--------------------------------------------------

[Table 2](#T2){ref-type="table"} shows clinical and surgical characteristics of patient groups, according to dominant valvular pathology. Group I (AS) was characterized by a higher mean age with higher prevalence of hypertension, diabetes, and coronary artery disease. Almost all of these patients (879 \[99%\]) underwent AV replacement with relatively frequent use of tissue valve (329 \[37%\]). The proportion of combined aortic surgery in group I (383 \[43%\]) was similar to that of group II (86 \[43%\]). Aortic aneurysm was the most common cause of aortic surgery, and aortic dissection was rarely observed in either group I (6 \[2%\]) or group II (1 \[1%\]). Group II was characterized by younger age (47±14 years) and a higher proportion of males (173 \[87%\]) compared to group I. Group II also presented with more cases of increased LV mass and cavity size, as well as more dilated aortic root at the Valsalva sinus and sinotubular junction levels. Thirty-nine (20%) patients in group II underwent AV repair, which was significantly more frequent than in group I (13 \[1%\]). Only 2 patients (2%) in group II presented with coarctation of aorta, while this was not observed in other groups. Patients in group III with infective endocarditis were younger on average (44±15 years). Although 54 patients (78%) in this group had moderate or severe AR, only 3 patients (4%) were feasible candidates for AV repair. Aortic root abscess (17 \[89%\]) was the main pathology in 19 cases (28%) with combined aortic surgery in group III.

###### Characteristics according to primary cause of AV surgery
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  Variables                    AS (group I)           AR (group II)   Infective endocarditis (group III)   p value^\*^   
  ---------------------------- ---------------------- --------------- ------------------------------------ ------------- ---------
  Number of patients           892 (77)               199 (17)        69 (6)                               \-            
  Age (years)                  62±10^†^               47±14           44±15                                \<0.001       
  Male gender                  531 (60)^†^            173 (87)        59 (86)                              \<0.001       
  Hypertension                 352 (40)               65 (33)         12 (17)                              \<0.001       
  Diabetes                     133 (15)^†^            6 (3)           6 (9)                                \<0.001       
  Coronary artery disease      142 (16)^†^            16 (8)          4 (6)                                0.002         
  LV mass index (g/m^2^)       160±56^†^              217±72          180±65                               \<0.001       
  LV ejection fraction (%)     58±12^†^               52±10           57±9                                 \<0.001       
  LV diastolic diameter (mm)   51±7^†^                69±9            62±10                                \<0.001       
  LV systolic diameter (mm)    33±9^†^                48±10           40±9                                 \<0.001       
  Aortic diameters (mm)                                                                                                  
                               LV outflow tract       22±2^†^         26±4                                 24±3          \<0.001
                               Valsalva sinus         33±5^†^         40±8                                 36±5          \<0.001
                               Sinotubular junction   30±5^†^         34±7                                 30±5          \<0.001
                               Ascending aorta        42±7            42±8                                 39±7          0.018
  Types of AV surgery                                                                                      \<0.001       
                               Replacement            879 (99)^†^     160 (80)                             66 (96)       
                               Valvuloplasty          13 (1)^†^       39 (20)                              3 (4)         
  Types of prosthetic valve                                                                                \<0.001       
                               Mechanical valve       550 (63)^†^     138 (86)                             57 (86)       
                               Tissue valve           329 (37)^†^     20 (14)                              9 (14)        
  Prosthetic valve size (mm)   22±2^†^                25±3            24±2                                 \<0.001       
  Coronary artery bypass       103 (12)^†^            5 (3)           3 (4)                                \<0.001       
  Combined aortic surgery      383 (43)               86 (43)         19 (28)                              0.042         
  Cause of aortic surgery                                                                                  \<0.001       
                               Aortic dissection      6 (2)           1 (1)                                0 (0)         
                               Aortic aneurysm        377 (98)        83 (97)                              2 (11)        
                               Aortic root abscess    0 (0)           0 (0)                                17 (89)       
                               Coarctation of aorta   0 (0)           2 (2)                                0 (0)         

Values are presented as mean±standard deviation or number of patients (%).

AR = aortic regurgitation; AS = aortic stenosis; AV = aortic valve; LV = left ventricle.

^\*^p value among 3 groups; ^†^Significant difference presented between groups with aortic stenosis and regurgitation.

BAV morphological phenotypes
----------------------------

[Figure 4](#F4){ref-type="fig"} shows the distribution of BAV morphological phenotypes overall and at individual centers. Type 1 was the most frequent (622 \[53%\]), followed by type 2 (313 \[27%\]), type 4 (183 \[16%\]) and type 3 (42 \[4%\]). This trend was similar in each center but significant variability in proportions was observed by center (p\<0.001). The most frequent phenotype was type 1 which ranged from 44% to 59%. The frequency of type 1 was significantly higher in AR than in AS (74% vs. 49%; p\<0.001).

![BAV phenotypes in overall and individual centers. BAV morphological phenotypes were classified into 4 type: type 1, RCC-LCC fusion; type 2, RCC-NCC fusion; type 3, LCC-NCC fusion; and type 4, indistinguishable between type 2 and 3.\
BAV = bicuspid aortic valve; LCC = left coronary cusp; NCC = non-coronary cusp; RCC = right coronary cusp.](kcj-48-48-g004){#F4}

DISCUSSION
==========

We described the clinical features, current practice patterns, and morphological phenotypes in a large patient group with BAV, which is the first report of this kind in Korea. BAV has historically been considered an ominous disease, which is likely due to sporadic reports on fatal infective endocarditis[@B14] and aortic dissection or histologic similarity to Marfan\'s disease, based on an excised aorta.[@B10] Recent representative clinical studies revealed that perceptions about the fatality of BAV have been biased or exaggerated, resulting from a lack of clinical evidence. Patients with BAV actually have similar overall survival rates compared to the general population.[@B7][@B8] Moreover, the risk of aortic dissection was found to be as low as 0.5% in a 25-year follow-up.[@B9] Nevertheless, these clinical studies also provided information about the risk for aortic aneurysm, which was 26% in a 25-year follow-up,[@B9] and approximately 27% of the patients underwent AV or aortic surgery during a 20-year follow-up.[@B7] These findings are a reminder that development of valvular disease and aortic aneurysm that require surgery is an actual lifetime health risk. In this context, data focused on indications for AV surgery and clinical features in Korean patients with BAV are beneficial for improving patient care.

We have shown that development of valvular dysfunction (AS or AR) and infective endocarditis was the main cause of AV surgery, and AS was the predominant lesion for AV surgery (77% \[892/1,160\]). Interestingly, there was a unique relationship between age and predominant valvular lesions that required AV surgery. Surgery for AS before 60 years of age was reported to represent premature degeneration of BAV,[@B15] and BAV is more frequent than tricuspid AV in younger ages based on data for AV replacement.[@B16] However, in our study, surgery for AS due to BAV was mainly performed in the aged population and more than 90% (811/892) of patients who underwent surgery were older than 50 years. The second common cause of AV surgery in patients with BAV was development of AR and the mean age was significantly lower for those with AR than AS (47±14 vs. 62±10 years; p\<0.001). More than 50% (104/199) underwent AV surgery due to AR before age 50. Infective endocarditis was the primary lesion for AV surgery in 6% of cases, comprising the smallest proportion. However, this number is not negligible, considering the prevalence of BAV in the general population and the volume of AV surgery. Infective endocarditis developed in relatively young patients and more than 60% of patients (43/69) underwent surgery before 50 years of age. Aortic root abscess was observed in 25% of patients with infective endocarditis, which is comparable with the previously reported frequency (22%) in patients with AV endocarditis[@B17] but lower than that (50%) in specified BAV endocarditis groups.[@B18] The relationship between age and predominant valvular lesions that required AV surgery in our patients with BAV is similar to that reported previously: In a surgical pathology study of 542 cases, the authors confirmed that AS surgery was predominantly performed in the aged population with the peak in the 60s.[@B19]

Although BAV has unique morphological features with recognizable patterns, its clinical impact or significance has remained elusive. Different classification systems for BAV phenotypes have been reported since the 1970s.[@B19]^-^[@B21] The current representative classification was proposed by Sievers and Schmidtke,[@B12] who applied a sophisticated method to 304 surgical reports and derived 3 main and 6 subcategories. This system was utilized by other researchers who demonstrated the feasibility of AV repair based on detailed anatomic features.[@B22] However, such a classification process is difficult to reproduce in routine practice using non-invasive imaging studies alone, which are limited in their ability to document fused individual cusps; moreover, its benefit is doubtful as 95% of patients undergo AV replacement rather than repair surgery. Conversely, the influence of BAV phenotype on hemodynamics has been highlighted recently.[@B23][@B24][@B25] Most of these studies, however, used magnetic resonance images for better spatial resolution, which is inconsistent with real clinical practice, in which echocardiography remains the mainstay of diagnosis. Therefore, we investigated the classification system presented by Schaefer et al.,[@B13] in which echocardiographic images were used to derive 3 main patterns. In this study, due to the potential ambiguity of real images, we added a type 4 that represented indeterminate patterns between types 2 and 3.

We confirmed that type 1 (fusion between right and left coronary cusp) was the most frequent phenotype despite some variations in the frequency between the 4 institutions. Notably, the relative frequency of the type 1 phenotype in our study was lower compared to that reported in western countries, suggesting the possibility of ethnic differences in the frequency of different BAV phenotypes. The prevalence of the type 1 phenotype in western countries was over 70% (up to 86%), whereas that reported in Japan and Korea was less than 60% ([Table 3](#T3){ref-type="table"} and [Figure 5](#F5){ref-type="fig"}).[@B7][@B8][@B12][@B13][@B26][@B27][@B28] One potential explanation for this difference is different study cohorts: our study included BAV patients with significant valvular dysfunction that needed AV surgery, whereas western reports based on imaging studies included variable degrees of valve dysfunction. Currently, the clinical impact of ethnic differences on the frequency of specific BAV phenotypes is unclear; however, considering the different embryologic pathogenesis of different BAV phenotypes,[@B29] these could manifest in ethnically-based differences in clinical features or outcomes in patients with BAV. This hypothesis requires additional testing in future investigations.

###### BAV phenotypes described in previous research
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  Authors (reference)           Number of patients   Age                       Valve functions                                                                  Modality           Nation    Phenotype distribution
  ----------------------------- -------------------- ------------------------- -------------------------------------------------------------------------------- ------------------ --------- -------------------------------------------------------------------------------------
  Fernandes et al.[@B27]        1,135                Median 3 (range, 0--18)   Subgroup analysis (n=864); moderate/severe AS (14%), moderate/severe AR (4.5%)   TTE                US        RL (70%), RN (28%), LN (1%)
  Sievers and Schmidtke[@B12]   304                  53±15                     All surgically corrected lesions; AS (51%), AR (38%), ASR (9%), normal (1%)      Operative report   Germany   RL (73%), RN (15%), LN (3%), Lat^\*^ (4%), Unicuspid (5%)
  Schaefer et al.[@B13]         192                  45±14                     Moderate/severe ASR (5.8%), normal (11%)                                         TTE                US        RL (79%), RN (20%), LN (1%)
  Michelena et al.[@B7]         212                  32±20                     Normal or minimal dysfunction                                                    TTE                US        RL (typical, 86%), other types (atypical, 14%)
  Tzemos et al.[@B8]            510                  35±16                     Moderate/severe AS/AR (37%)                                                      TTE                Canada    RL (anterior-posterior orientation, 75%), other types (right-left orientation, 25%)
  Kinoshita et al.[@B28]        135                  64±12                     All surgically corrected lesions; AS (42%), AR (31%), ASR (27%)                  Operative report   Japan     RL (53%), other types (Non RL, 47%)

AR = aortic regurgitation; AS = aortic stenosis; ASR = both aortic stenosis and regurgitation; BAV = bicuspid aortic valve; CT = computed tomography; Lat = lateral; LN = fusion between left and non-coronary cusps; RL = fusion between right and left coronary cusps; RN = fusion between right and non-coronary cusps; TTE = transthoracic echocardiography.

^\*^Lat, BAV presenting with 2 even cusps, no raphe and right-left orientation.

![BAV phenotypes described in previous research.\
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This study is limited in that we only included patients who underwent AV surgery in tertiary referral hospitals, and thus, the actual incidence of valvular dysfunction or aortic dissection/aneurysm in the general population cannot be accurately estimated based on these results. This selection bias may have also affected the frequency of BAV phenotypes in real clinical practice, which includes patients with mild or no valvular dysfunction. Moreover, although aortic complication is common in patients with BAV, our retrospective study was not ideal for adequately evaluating this important clinical outcome. Patients who underwent primary aortic surgery without AV surgery were not included in this study.

In summary, clinical characteristics of patients with BAV who underwent AV surgery were studied according to the 3 different valvular lesions for surgery (AS, AR, and infective endocarditis). We observed a possible ethnic difference in a specific BAV phenotype and a potential association with types of valvular dysfunction. Further investigations are necessary to evaluate whether these observations may be applied in daily clinical practice for the general population.
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